Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication September 14, 2011
- Accepted for publication September 16, 2011
- Published online December 5, 2011.
Article Versions
- previous version (November 8, 2011 - 09:57).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2011 by Society of Nuclear Medicine
Author Information
- Helena R. Balon1,
- Tracy L.Y. Brown2,
- Stanley J. Goldsmith3,
- Edward B. Silberstein4,
- Eric P. Krenning5,
- Otto Lang6,
- Gary Dillehay7,
- Jennifer Tarrance, CNMT1,
- Matt Johnson, CNMT1 and
- Michael G. Stabin8
- 1William Beaumont Hospital, Royal Oak, Michigan
- 2University of Arkansas for Medical Sciences, Little Rock, Arkansas
- 3New York Hospital–Cornell Medical, New York, New York
- 4University of Cincinnati Medical Center, Cincinnati, Ohio
- 5Erasmus University Medical Center, Rotterdam, The Netherlands
- 63rd Medical School, Charles University, Prague, Czech Republic
- 7Northwestern University, Chicago, Illinois; and
- 8Vanderbilt University Medical Center, Nashville, Tennessee
- For correspondence or reprints contact: Helena Balon, William Beaumont Hospital, 3601 W. Thirteen Mile Rd., Royal Oak, MI 48703. E-mail: hbalon{at}beaumont.edu
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
- Article
- Abstract
- PREAMBLE
- I. INTRODUCTION
- II. GOALS
- III. DEFINITIONS
- IV. EXAMPLES OF CLINICAL AND RESEARCH INDICATIONS
- V. QUALIFICATIONS AND RESPONSIBILITIES OF PERSONNEL (IN THE UNITED STATES)
- VI. PROCEDURE/SPECIFICATIONS OF THE EXAMINATION
- VII. DOCUMENTATION/REPORTING
- VIII. EQUIPMENT SPECIFICATION
- IX. QUALITY CONTROL AND IMPROVEMENT, SAFETY, INFECTION CONTROL, AND PATIENT EDUCATION CONCERNS
- X. RADIATION SAFETY IN IMAGING
- XI. ISSUES REQUIRING FURTHER CLARIFICATION
- Acknowledgments
- XIV. APPROVAL
- Footnotes
- XIII. REFERENCES
- Figures & Data
- Info & Metrics
Related Articles
Cited By...
- Can 68Ga-DOTA Peptides Be Potential Radiotracers for PET Imaging of the Spleen?
- Clinical History of the Theranostic Radionuclide Approach to Neuroendocrine Tumors and Other Types of Cancer: Historical Review Based on an Interview of Eric P. Krenning by Rachel Levine
- Improving Tools and Options for the Management of Patients with Neuroendocrine Tumors: A Patient Perspective
- 68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
- Significance of a Single-Time-Point Somatostatin Receptor SPECT/Multiphase CT Protocol in the Diagnostic Work-up of Gastroenteropancreatic Neuroendocrine Neoplasms
- 64Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with 111In-DTPA-Octreotide in 112 Patients
- Carcinoid syndrome caused by a serotonin-secreting pituitary tumour
- Clinical PET of Neuroendocrine Tumors Using 64Cu-DOTATATE: First-in-Humans Study
- Updated Practice Guideline for Somatostatin Receptor Scintigraphy